German molecular diagnostics firm GNA Biosolutions picks up $13.5 mln Series C

GNA Biosolutions GmbH, a German molecular diagnostics company, has secured $13.5 million in Series C financing. The investors included GreyBird Ventures, Occident, Wachtumsfonds Bayern, SHS Gesellschaft für Beteiligungsmanagement, Robert Bosch Venture Capital, UVC Partners, Mey Capital Matrix, KfW and btov Partners.

North AmericaUSHealthcareBriefs